Login to Your Account

Esperion Spins Out of Pfizer, Brings in $22.8M in Series A

By Tiffany Turner

Friday, May 2, 2008
Four years after purchasing Esperion Therapeutics Inc., a company focused on the discovery and development of compounds for cardiovascular and metabolic disease, Pfizer Inc. is selling the Ann Arbor, Mich.-based firm to an entity funded by a group of investors. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription